Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
pfizer
5
×
boston blog main
boston top stories
new york blog main
new york top stories
biotech
cancer
deals
gene therapy
national
novartis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
biogen
boulder/denver blog main
boulder/denver top stories
car-t
celgene
clinical trials
crispr
detroit blog main
detroit top stories
drugs
hemophilia
indiana blog main
indiana top stories
ipo
medicaid
medicare
raleigh-durham blog main
raleigh-durham top stories
roche
sangamo therapeutics
seattle blog main
seattle top stories
What
gene
5
×
therapy
bio
drug
roundup
access
advanced
alnylam
alzheimer’s
approves
becker
billions
capacity
car
cell
cells
close
companies
consolidation
crispr
data
different
dollars
eaton
ema
employ
europe
fail
falcon
fda
focus
follows
forward
harmful
healthcare
heated
hemophilia
hits
impact
increases
Language
unset
Current search:
pfizer
×
gene
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug